Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PRCY - ANY BODY HAS ANY NEWS ON THESE -- Ignore unavailable to you. Want to Upgrade?

To: Peter H. Proctor who wrote (283)	12/9/1997 12:22:00 PM
From: Susan Saline	Respond to of 670

Hi all, The down trend chart is holding this back from any rebound. I follow this often and hold some, long. Looking to average down again near the end of the month. Have patience, this company is making a try at changing the business plan, and that takes time. Sue

To: Peter H. Proctor who wrote (283)	12/9/1997 1:04:00 PM
From: VultureInvest	Respond to of 670

The vutures are around waiting patiently until the seller is finished with his bitter spree. By the way, there products are being touted at some internet sites so all can't be that bad. By the way your "M&A" statement replicates my thoughts in a previous posting to this group. Perhaps a new emerging company in the same wound healing/hair growth market needing manufacturing capabilities will consider the PRCY prospects. The Vulture

To: Peter H. Proctor who wrote (283)	12/9/1997 6:41:00 PM
From: Vip	Read Replies (1) \| Respond to of 670

Dr. P: <What surprises me is that the M&A department of some drug company hasn't snatched this one up.> Actually, that is what concerns me. That it has not happened long ago. My question is this due to the fact that their products are not economically viable or is it due to an entrenched BOD and management hiding behind <a poison pill in place>?? :~<< no <G> at this juncture! I think it is fair to say that the company's management has failed to land significant partnerships to market their approved products and land research grants to continue with Phase III of Tricomin. The stockholders have been stiffed. To add: the Chairman is an insult to injury based upon his selling of shares through out this year. Vip

To: Peter H. Proctor who wrote (283)	4/19/1998 11:00:00 PM
From: geewiz	Read Replies (1) \| Respond to of 670

Hi Peter, I'm still long on PRCY and am encouraged by the recent increase in revenues. The potential seems to lay with the cosmetic wound healing market for both transplants and wrinkle removal. What are your thoughts of the company doing their own marketing on these products? Will PRCY be able to cover the potential markets with their own sales reps? Any indication when the shampoo will be introduced? I looked at the C.R.Bard web site and am surprised this company is marketing the surgical wound care gel. Bard appears to be more of a medical device company: crbard.com Thanks for your thoughts, best,art